MicroRNA (miRNA) Market Expected To Reach USD 415.1 Million By Year 2026 | Top key Players Agilent Technologies, Alnylam Pharmaceuticals, Bio-Rad Laboratories, GeneCopoeia, Inc

According to the current analysis of Reports and Data, the global MicroRNA (miRNA) Market was valued at USD 171.4 Million in 2018 and is expected to reach USD 415.1 Million by year 2026, at a CAGR of 11.6% percent. The study covers different types of products which can boost up the market and the technology and the services available in this market for gene silencing. Gene silencing via RNA interference (RNAi) is rapidly evolving as a personalized approach to cancer treatment. The effector molecule i.e. MicroRNA (miRNA)--can be used to "switch off" specific cancer genes. Quite recently, they have been examined as innovative classes of therapeutic agents for healing a broad range of syndromes including cancers and infections.

Get a Sample Copy of this Report before you purchase free of cost! @ https://www.reportsanddata.com/sample-enquiry-form/1418

Companies considered and profiled in this market study:

The Global miRNA Market study postulates constructive intuition globally which includes the companies who are the key players in Global miRNA Market, such as Agilent Technologies, Alnylam Pharmaceuticals, Bio-Rad Laboratories, GeneCopoeia, Inc., Illumina, Inc., Merck KGaA, Miltenyi Biotec, NanoString Technologies, Inc., New England Biolabs, Inc., QIAGEN (Exiqon), Rosetta Genomics, Thermo Fischer Scientific Inc

Key recent developments in the field of miRNA market include development of new product tools. For instance, in 2019, the NanoString Technologies Inc. launched the GeoMx(TM) Digital Spatial Profiler facilitating highly-multiplexed spatial profiling of RNA and protein targets in a variety of sample types, including FFPE tissue sections.

Government investment and advancements in technology are anticipated to further drive growth. High prevalence of diseases is expected to encourage pharmaceutical and biotech companies to engage in R&D in different disease classes. Expansion, authorisation, and launch of products for use in hospitals and clinics face various challenges due to reproducibility and consistency issues.

Segments covered in the report:

For the purpose of the study, this Reports and Data has segmented the Global MicroRNA (miRNA) Market on the basis of product type, research tools and services type, application, end user and the regional outlook:

Global MicroRNA (miRNA) Key Market Segments:

Product Type: (Revenue, USD Million; 2016-2026)
1. Instruments
2. Kits, Reagents & Consumables
3. Isolation & Purification
4. Quantification & Detection
5. Functional Analysis
6. Others

Research Tools and Services: (Revenue, USD Million; 2016-2026)
1. Tools
2. qRT-PCR
3. Biomarkers
4. Next Gen Sequencing (NGS)
5. Microarray Analysis Tools
6. Functional Analysis Tools
7. Extraction Tools
8. Others
9. Services
10. miRNA cDNA Synthesis
11. Quantification Services
12. Others

Grab Your Report at an Impressive Discount! Please Click Here @ https://www.reportsanddata.com/discount-enquiry-form/1418

Application: (Revenue, USD Million; 2016-2026)
1. Cancer
2. Infectious Diseases
3. Immunological Disorder
4. Cardiovascular Disease
5. Neurological Disease
6. Others

End Use: (Revenue, USD Million; 2016-2026)
1. Academic & Research Institutes
2. Biopharmaceutical Companies
3. CRO
4. Diagnostic Centres

Regional Outlook: (Revenue, USD Million; 2016-2026)
1. North America
2. Asia Pacific
3. Latin America
4. Middle East and Africa (MEA)

Further key findings from the report suggest:

1. miRNA Market is fastest growing at a CAGR of 6% in Asia Pacific followed by Europe respectively. High progress in genomics and upcoming M&A deals are the key factors to propel the market growth during forecast period across these

2. qRT-PCR segment type has the largest market share of 37.3%

3. Microarray Analysis Tools are also one of the key technologies employed in the functional studies of these molecules which drive the market for miRNA with a CAGR of 11.2%

4. Europe accounts for the second largest market share of the global miRNA market at 29.2% due to huge approval of fund through European Union

5. The Pharmaceutical and Biotech Companies end use segment is expected to register largest CAGR of 11.8% during 2019-2026 due to rapid usage of research tools

6. United States, France, Germany, United Kingdom, China, Israel, and Korea are the significant players interested in evaluating the potential of miRNA in the global market

To Buy This Report, Click Here @ https://www.reportsanddata.com/checkout-form/1418

Key selling points of this research study

1. The study gives an in-depth evaluation of the evolving competitive scenario that gives the reader/client a competitive edge.

2. It offers a holistic view of all critical aspects boosting or limiting the growth of the sector

3. The market intelligence report derives an eight-year forecast, including historical, contemporary, and potential market prospects, projecting the estimated progress of the market.

4. It aids informed decision-making by offering an exhaustive database of the pivotal market segments and sub-segments.

Contact Us:

John Watson
Head of Business Development
Reports and Data
40 Wall St. 28th floor New York City, NY 10005 United States
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com

About Us:

We are a boutique market intelligence and strategic consulting firm dedicated to make an meaningful impact on businesses across the globe. Our stellar estimation and forecasting models have earned recognition across majority of the business forum across the globe. Our services are arrayed over diverse sectors and industries looking to expand in alternative regions and products.

This release was published on openPR.